Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
The DOI matches its Crossref record; 443 of the 443 references it cites were found in a registry or an index.
Abstract
Design and functionalization strategies for multifunctional nanocarriers (e.g., nanoparticles, micelles, polymersomes) based on biodegradable/biocompatible polymers intended to be employed for active targeting and drug delivery are reviewed. This review will focus on the nature of the polymers involved in the preparation of targeted nanocarriers, the synthesis methods to achieve the desired macromolecular architecture, the selected coupling strategy, the choice of the homing molecules (vitamins, hormones, peptides, proteins, etc.), as well as the various strategies to display them at the surface of nanocarriers. The resulting morphologies and the main colloidal features will be given as well as an overview of the biological activities, with a special focus on the main in vivo achievements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Today, PLA resin has been approved by the FDA and European regulatory authorities for use in food- and drug-delivery systems [12,34].”
From Synthesis and Biological Application of Polylactic Acid (2020) · cites this paper as [34]
Citations
Cites
Items 401–443 of 443
Han, J.-H., Oh, Y., Kim, D., & Kim, C. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00206-9 · Cited by 50
Grabrucker, A. M., Garner, C. C., Boeckers, T. M., Bondioli, L., Ruozi, B., Forni, F., Vandelli, M. A., & Tosi, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017851 · Cited by 49
Polymeric Nanomaterials for Islet Targeting and Immunotherapeutic Delivery
Ghosh, K., Kanapathipillai, M., Korin, N., McCarthy, J. R., & Ingber, D. E. (2011) · Nano Letters · doi:10.1021/nl203334c · Cited by 49
EGFP-EGF1 protein-conjugated PEG–PLA nanoparticles for tissue factor targeted drug delivery
Mei, H., Shi, W., Pang, Z., Wang, H., Lu, W., Jiang, X., Deng, J., Guo, T., & Hu, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.055 · Cited by 46
Rahmat, D., Khan, M. I., Shahnaz, G., Sakloetsakun, D., Perera, G., & Bernkop‐Schnürch, A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.046 · Cited by 45
Liu, P., Li, Z., Zhu, M., Sun, Y., Li, Y., Wang, H., & Duan, Y. (2009) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-009-3925-8 · Cited by 44
Sahu, S. K., Maiti, S., Maiti, T. K., Ghosh, S. K., & Pramanik, P. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201000353 · Cited by 44
Structure, Function, and Activation of Coagulation Factor VII
Eigenbrot, C. W. (2002) · Current Protein and Peptide Science · doi:10.2174/1389203023380675 · Cited by 41
Cao, W., Zhou, J., Wang, Y., & Zhu, L. (2010) · Biomacromolecules · doi:10.1021/bm101154r · Cited by 41
Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method
Nah, J., Paek, Y., Jeong, Y.-I., Kim, D. W., Cho, C., Kim, S., & Kim, M.-Y. (1998) · Archives of Pharmacal Research · doi:10.1007/bf02974636 · Cited by 40
Selectins Ligand Decorated Drug Carriers for Activated Endothelial Cell Targeting
Banquy, X., Leclair, G., Rabanel, J., Argaw, A., Bouchard, J., Hildgen, P., & Giasson, S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800257m · Cited by 40
Yusuf‐Makagiansar, H., & Siahaan, T. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011007014510 · Cited by 39
Novel gelatin–siloxane nanoparticles decorated by Tat peptide as vectors for gene therapy
Wang, Z., Zhao, Y., Ren, L., Jin, L., Sun, L., Yin, P., Zhang, Y., & Zhang, Q. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/44/445103 · Cited by 38
Taheri, A., Dinarvand, R., Atyabi, F., Nouri, F. S., Ahadi, F., Ghahremani, M. H., Ostad, S. N., Borougeni, A. T., & Mansoori, P. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1340 · Cited by 38
Li, Y., Zhang, Y., Yang, D., Hu, J., Lu, G., & Huang, X. (2010) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/pola.23976 · Cited by 37
Design of a multifunctional heparin-based nanoparticle system for anticancer drug delivery
Li, L., Huh, K. M., Lee, Y.-K., & Kim, S. Y. (2010) · Macromolecular Research · doi:10.1007/s13233-009-0134-8 · Cited by 36
Debotton, N., Parnes, M., Kadouche, J., & Benita, S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.014 · Cited by 35
Upadhyay, K. K., Bhatt, A. N., Castro, E., Mishra, A. K., Chuttani, K., Dwarakanath, B. S. R., Schatz, C., Meins, J. L., Misra, A. R., & Lecommandoux, S. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.201090008 · Cited by 35
Isolation of scFvs to In Vitro Produced Extracellular Domains of EGFR Family Members
Horak, E. M., Heitner, T., Robinson, M. K., Simmons, H. H., Garrison, J. L., Russeva, M., Furmanova, P., Lou, J., Zhou, Y., Yuan, Q., et al. (2005) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2005.20.603 · Cited by 34
Stella, B., Marsaud, V., Arpicco, S., Géraud, G., Cattel, L., Couvreur, P., & Renoir, J. (2007) · Journal of drug targeting · doi:10.1080/10611860600935826 · Cited by 34
Self-citationGao, Y., Gu, W., Chen, L., Xu, Z., & Li, Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.006 · Cited by 34
Zou, A., Huo, M., Zhang, Y., Zhou, J., Yin, X., Yao, C., Zhu, Q., Zhang, M., Ren, J., & Zhang, Q. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22798 · Cited by 32
Droumaguet, B. L., Souguir, H., Brambilla, D., Verpillot, R., Nicolas, J., Taverna, M., Couvreur, P., & Andrieux, K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.015 · Cited by 31
Self-citationZu, Y.-G. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s27157 · Cited by 31
Santra, S., & Pérez, J. M. S. (2011) · Biomacromolecules · doi:10.1021/bm2009334 · Cited by 31
Immunomodulation and Sezary syndrome: experience with thymopentin (TP-5)
Bernengo, M. G., Doveil, G. C., MEREGALLI, M., Appino, A., & Massobrio, R. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb03203.x · Cited by 30
Ji, J., Wu, D., Liu, L., Chen, J., & Xu, Y. (2011) · Polymer Bulletin · doi:10.1007/s00289-011-0690-x · Cited by 30
Nie, Y., Zhang, Z., Li, L., Luo, K., Ding, H., & Gu, Z. (2009) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-009-3750-0 · Cited by 29
Benn, S. C., Ay, İ., Bastia, E., Chian, R.-J., Celia, S. A., Pepinsky, R. B., Fishman, P. S., Brown, R. H., & Francis, J. W. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03459.x · Cited by 28
Polt, R. L., & Palian, M. M. (2001) · Drugs of the Future · doi:10.1358/dof.2001.026.06.668342 · Cited by 26
Li, L., Kim, J. K., Huh, K. M., Lee, Y.-K., & Kim, S. Y. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.10.030 · Cited by 25
EGF mediates multiple signals: dependence on the conditions
Kamer, A. R., Sacks, P. G., Vladutiu, A. O., & Liebow, C. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.13.1.143 · Cited by 19
Mao, S.-Y. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-324-0_7 · Cited by 18
Hammady, T. M., Rabanel, J., Dhanikula, R. S., Leclair, G., & Hildgen, P. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.01.007 · Cited by 18
Trans-Activating Transcriptional Activator (TAT) Peptide-Mediated Brain Drug Delivery
Rao, K. S., & Labhasetwar, V. (2006) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2006.036 · Cited by 17
Polymeric Nanoparticles as Drug Carriers
Hillaireau, H., & Couvreur, P. (2006) · CRC Press eBooks · doi:10.1201/9781420021677-8 · Cited by 17
Self-citationVascular Endothelium in Inflamed Tissue as a Target for Site Selective Delivery of Drugs
Everts, M., Schraa, A. J., de Leij, L. F. M. H., Meijer, D. K. F., & Molema, G. (2001) · Methods and principles in medicinal chemistry · doi:10.1002/352760006x.ch7 · Cited by 16
Yang, J., Cho, E., Seo, S., Lee, J., Yoon, H., Suh, J., Huh, Y., & Haam, S. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31312 · Cited by 16
Folic acid‐conjugated depolymerized quaternized chitosan as potential targeted gene delivery vector
Morris, V. B., Pillai, C. K. S., & Sharma, C. P. (2011) · Polymer International · doi:10.1002/pi.3047 · Cited by 14
Transferrin-mediated PEGylated nanoparticles for delivery of DNA/PLL
Gu, W., Xu, Z., Gao, Y., Chen, L., & Li, Y. (2006) · Nanotechnology · doi:10.1088/0957-4484/17/16/026 · Cited by 9
RGD-Conjugated PLA-PLL Nanoparticles Targeting to Bacp-37 Breast Cancer Xenografts In Vivo
Liu, P., Qi, X., Sun, Y., Wang, H., Li, Y., & Duan, Y. (2011) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2011.3945 · Cited by 9
Beketić-Orešković, L., Šarčević, B., Malenica, B., & Novak, D. (1993) · PubMed · Cited by 7
Kolb (2001) · doi:10.1002/1521-3773(20010601)40:11<2004::aid-anie2004>3.0.co;2-5
Research works printed but not linked: 24
- Erb, 2009, Drug Delivery Syst., 24, 63
- Marty, 1978, Pharm. Acta Helv., 53, 17
- Gabizon, 1994, Cancer Res., 54, 987
- Goren, 2000, Clin. Cancer Res., 6, 1949
- Ross, 1994, Cancer, 73, 2432, 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S · DOI · Paper page
- Eliaz, 2001, Cancer Res., 61, 2592
- Damjanov, 1987, Lab. Invest., 57, 5
- Casy, 1988, J. Clin. Pharmacol., 28, 191
- Beketic-Oreskovic, 1993, Neoplasma, 40, 69
- Ona, 1973, Cancer, 31, 324, 10.1002/1097-0142(197302)31:2<324::AID-CNCR2820310208>3.0.CO;2-Y · doi:10.1002/1097-0142(197302)31:2<324::aid-cncr2820310208>3.0.co;2-y
- Peipp, 2002, Cancer Res., 62, 2848
- Lupold, 2002, Cancer Res., 62, 4029
- Moro, 1997, Cancer Res., 57, 1922
- Nie, 2009, J. Mater. Sci.: Mater. Med., 20, 1849
- Liu, 2010, J. Mater. Sci.: Mater. Med., 21, 551
- Yousefpour, 2011, Int. J. Nanomed., 6, 1977
- Sahu, 2010, J. Mater. Sci.: Mater. Med., 21, 1587
- Taheri, 2011, Int. J. Nanomed., 6, 1863
- Tian, 2012, Int. J. Nanomed., 7, 1031
- Nicolas, 2009, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 1, 111
- Harper, 1999, Clin. Cancer Res., 5, 4242
- Armstrong, 1994, Cancer Res., 54, 5280
- Kamer, 2004, Int. J. Mol. Med., 13, 143
- Colle, 1988, Curr. Ther. Res. Clin. E, 44, 1045
Cited by
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
Chen, G., Roy, I., Yang, C., & Prasad, P. N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00148 · Cited by 1,499
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Metadata
- Authors
- Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Nicolas, Julien
- Venue
- Chem. Soc. Rev.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 42
- Issue
- 3
- Pages
- 1147-1235
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2027432937
- Cited by
- 1,270
- References
- 443
- Citations by year
- 2026: 25 · 2025: 46 · 2024: 61 · 2023: 78 · 2022: 75 · 2021: 85 · 2020: 90 · 2019: 125 · 2018: 131 · 2017: 136 · 2016: 140 · 2015: 121 · 2014: 102 · 2013: 54
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Society Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- targeted drug delivery, biodegradable polymers, biocompatible polymers, nanocarriers, active targeting, polymersomes, micelles, nanoparticles, peptide conjugation, protein conjugation, surface functionalization, macromolecular architecture, colloidal properties, in vivo biodistribution
- MeSH terms
- Biocompatible Materials, Drug Carriers, Humans, Micelles, Models, Molecular, Polymers, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.